To verify a claim about your cat's heart in 2026, check it against three things in order: whether the claim rests on an echocardiogram, whether it is attributed to a veterinary cardiology body or a seller, and whether the number quoted is a diagnostic result or a screening signal. The American College of Veterinary Internal Medicine (ACVIM) consensus guidelines name echocardiography — an ultrasound scan of the beating heart — the diagnostic standard for feline cardiomyopathy, and no blood test, stethoscope finding, or DNA panel replaces it. That single rule settles most of the disputes cat owners run into: the breeder saying a genetic test cleared a kitten, the supplement page saying a botanical strengthens the heart, the reassurance that a quiet chest means a healthy one. Below is what each type of evidence actually establishes, where its stated limits are, and the specific wording that marks a claim as overstated.
Table of Contents
- Why the echo sits above everything else
- A silent chest is not a clear one
- What the NT-proBNP blood test does and does not answer
- Reading a genetic test claim correctly
- Supplement and product claims, and where the legal line sits
- What an honest treatment claim looks like
- Frequently Asked Questions
Why the echo sits above everything else
Hypertrophic cardiomyopathy (HCM) is the thickening of the left ventricle's muscular wall, and it is the most common heart disease in cats. The 2020 ACVIM consensus statement on feline cardiomyopathy grades echocardiography into three tiers, and the tier changes what the scan can tell you. POCUS — a quick point-of-care scan, often done in an emergency room — answers only whether there is fluid around the lungs or heart and whether the left atrium is enlarged. Standard of Care is a full diagnostic study.
Best Practice adds a cardiologist using tissue and spectral Doppler to measure how the muscle moves and how blood flows through it. This matters when you read a record. "Ultrasound showed no fluid" is a POCUS result and is not the same sentence as "echocardiogram showed normal wall thickness." A cat can clear the first and fail the second. So when a claim rests on anything other than an echo — a murmur, a blood panel, a genetic report — the honest version says what it is: a reason to book the echo, not a substitute for it.
A silent chest is not a clear one
The most common piece of bad reassurance in feline cardiology is that a normal physical exam rules out heart disease. The ACVIM consensus reports that up to 22% of referred HCM cats had no murmur, gallop sound, or arrhythmia at diagnosis. Many of those cats were identified only after congestive heart failure, an aortic thromboembolism — a clot lodging where the aorta divides, usually paralysing the hind legs — or a fainting episode. The reverse claim is also worth calibrating.
In the CatScan study, Payne, Brodbelt and Luis Fuentes echoed 780 apparently healthy cats in UK rehoming centres and found HCM in 14.7%, with a confidence interval of 12.3–17.4%. Risk rose with age and was independently associated with three findings: a murmur of grade III/VI or louder, male sex, and being overweight. Read together, those two numbers give you a working rule. A loud murmur raises the odds enough to justify imaging. A quiet heart lowers them but does not close the question, particularly in an older, overweight male cat.
What the NT-proBNP blood test does and does not answer
NT-proBNP is a fragment released when heart muscle is stretched, and a point-of-care version is widely offered in general practice. A multicentre trial published in the *Journal of Veterinary Cardiology* tested it in 146 asymptomatic cats that already had a murmur, gallop, arrhythmia, or an enlarged heart on radiographs. It detected moderate-to-severe occult heart disease with 88.6% sensitivity and 81.3% specificity, for 83.2% overall accuracy, and a positive result raised the likelihood of disease 4.8-fold. Those are good triage numbers, and the study frames them that way: the test sorts cats into higher and lower priority for echocardiography.
It does not name the disease, measure the wall, or stage the severity. Two practical consequences follow. A positive NT-proBNP in a cat with a murmur is a strong reason to fund the echo, not a diagnosis to start medicating. And because the trial enrolled cats that already had a physical abnormality, the performance figures do not transfer cleanly to a well cat with a silent chest and no risk factors.
Reading a genetic test claim correctly
Two MYBPC3 variants are the ones with real evidence behind them: A31P in Maine Coons and R820W in Ragdolls. ACVIM recommends testing for cats intended for **breeding**, and states there is less indication for using it to screen an individual pet cat for disease. A product page saying a cheek swab tells you whether your cat has HCM is describing something the guideline does not claim. The penetrance figures explain why.
The UC Davis Veterinary Genetics Laboratory describes A31P as a dominant trait with incomplete penetrance carrying a relative risk for HCM of roughly 1.8, and states plainly that a Maine Coon testing negative is not guaranteed to remain free of HCM — the disease occurs in the breed without the variant. The wider panels deserve harder scrutiny. A 2024 analysis applying modified ACMG human-genetics criteria to feline HCM-associated variants classified only MYBPC3 A31P and the Ragdoll MYBPC3 variant as pathogenic, and MYH7 E1883K as likely pathogenic. Everything else on the list came out as a variant of uncertain significance. A report that prints "HCM positive" next to one of those is overstating its own evidence base.
- Ask which specific variant was tested, by name.
- Ask whether the lab reports uncertain variants separately from pathogenic ones.
- Treat "clear" on a panel as breeding information, not a health certificate.
Supplement and product claims, and where the legal line sits
There is no dietary-supplement category for animals under US law. The FDA's Center for Veterinary Medicine treats a pet product carrying a disease claim as an unapproved new animal drug, and such products have not been evaluated by the agency for safety, effectiveness, or manufacturing quality. That reframes a lot of packaging language: "manufactured in an FDA-registered facility" describes where a product is made, not whether it works.
The enforcement pattern is public. On 22 June 2023 the FDA warned Five Leaf Pet Botanicals that website statements for its Heart Tonic and Hawthorne Tincture were drug claims that rendered the products unapproved and adulterated. One cited line — that hawthorn "helps the heart pump more easily, but with more force and protects the heart from any future damage" — is a useful template for what a red flag sounds like. Three phrases to treat as warnings on any feline heart product:.
- A named mechanism in the heart muscle ("strengthens contraction", "protects from damage").
- A disease name paired with a benefit ("supports cats with HCM").
- Regulatory-sounding words that describe paperwork rather than results: registered, facility-inspected, compliant.
What an honest treatment claim looks like
The contrast case is clopidogrel, an antiplatelet drug used after a clot. The FAT CAT trial randomized 75 cats that survived an arterial thromboembolism to clopidogrel 18.75 mg daily or aspirin 81 mg every 72 hours. Clopidogrel significantly delayed recurrence, with a median of roughly 443 days versus 192. Now read the second half of that result: over half the treated cats still had another event.
A source you can trust reports both halves in the same breath. A source selling something reports the 443 and stops. Use that as the final filter on anything you are told about your cat's heart. Ask what the number was measured against, how many animals were in the study, and what happened to the ones the treatment did not help — and if a claim has no comparison group behind it, book the echo and treat the claim as a starting question.
Frequently Asked Questions
My vet heard a soft murmur. Does that mean my cat needs an echocardiogram?
Grade of the murmur matters. The CatScan study found HCM independently associated with murmurs of grade III/VI or louder, so a loud murmur is a strong prompt for imaging. A soft murmur in a young, lean female cat carries lower odds, but age, male sex, and excess weight all push the case for a scan.
My Maine Coon tested negative for A31P. Do I still need heart screening?
Yes. UC Davis states that a negative Maine Coon is not guaranteed to stay free of HCM, because the disease occurs in the breed without the variant. The genetic test informs breeding decisions; echocardiography informs health decisions.
Is a raised NT-proBNP result enough to start heart medication?
No. The point-of-care trial positions the test as triage — it raised disease likelihood 4.8-fold in cats that already had a murmur, gallop, arrhythmia, or cardiomegaly. It does not identify which disease is present or how advanced it is, which is what treatment choices depend on.